The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical ...
The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed ...
A Dutch neuromodulation developer has raised $60 million to complete the development of its minimally invasive implant for people suffering from chronic migraines. Salvia BioElectronics’ device is ...
Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to ...
As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer ...
A new wave of innovation may reshape how clinicians approach some of the most persistent challenges in patient care. Non-invasive neuromodulation, a technique that uses gentle electrical stimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results